Ramirez-Flores, Maria F. *; Cadena-Trejo, Cinthya MSc +; Motte-Garcia, Emilio *; Juarez-Cruz, Isaac D. *; Fernandez-Garcia, Maria V. PhD ++; Gastelum-Strozzi, Alfonso PhD [S]; Alpizar-Rodriguez, Deshire PhD [//]; Hernandez-Garduno, Adolfo PhD [P]; Pelaez-Ballestas, Ingris PhD #
doi : 10.1097/RHU.0000000000001915
Volume 29(3) pgs. 113-171,e13-e18 April 2023
This approach has given important insights into other nonrheumatic diseases.
Murayama, Anju *,+; Mamada, Hanano *,++; Shigeta, Haruki *,+; Yoshinaga, Takamichi *; Saito, Hiroaki MD, PhD *,[S]; Yamashita, Erika *; Tanimoto, Tetsuya MD *,[//]; Ozaki, Akihiko MD, PhD *,[P]
doi : 10.1097/RHU.0000000000001922
Given the increasing number of novel and expensive drugs for rheumatoid diseases, the financial relationships between pharmaceutical companies and rheumatologists could be prevalent and substantial. However, little was known about the information in Japan.
Wu, Rouyi BM *; Jiang, Wei MM +; Sun, Yangkai BM *; Wu, Ling MM +; Di, Yazhen MD +; Wang, Jiapei MM +; Zhong, Shiling MM +; Wang, Wenbo BM *
doi : 10.1097/RHU.0000000000001925
The aim of this study was to examine the clinical significance of oxidative stress (OS)-related indices, including inflammatory markers and lipid and platelet (PLT) parameter, in coronary artery lesions (CALs) in Kawasaki disease (KD).
Sieiro Santos, Cristiana MD *; Sendino-Tenorio, Isabel MD +; Alvarez Castro, Carolina PhD *; Moriano Morales, Clara MD *; Cordero Coma, Miguel PhD +; Diez Alvarez, Elvira MD *
doi : 10.1097/RHU.0000000000001921
Evaluating the efficacy and refractoriness to treatment and determining factors associated with adverse outcomes in uveitis associated with spondylarthritis (SpA) are complicated by the lack of validated outcome measures.
Fautrel, Bruno MD *; Wu, Jianmin PhD +; Wang, Duzhe PhD +; Haladyj, Ewa MD +; van de Laar, Mart A. F. J. MD, PhD ++; Takeuchi, Tsutomu MD, PhD [S]
doi : 10.1097/RHU.0000000000001924
Fatigue is common in patients with rheumatoid arthritis (RA). We assessed the relative impact of pain and disease activity on improvements in fatigue in 2 phase 3 baricitinib clinical trials.
Joerns, Elena K. MD *; Mills, Brooke MD *; Makris, Una E. MD, MSc *,+; Adams, Traci N. MD ++; Bermas, Bonnie MD *
doi : 10.1097/RHU.0000000000001929
Women with interstitial pneumonia with autoimmune features (IPAFs), a subset of interstitial lung disease (ILD), are at risk for pregnancy complications. Family planning discussions improve pregnancy outcomes in women with ILD.
Eggleston, Reid H. MD *; Baqir, Misbah MBBS +; Varghese, Cyril MD, MS ++,[S]; Pennington, Kelly M. MD +; Bekele, Delamo I. MBBS [//]; Hartman, Thomas E. MD [P]; Ernste, Floranne C. MD [//]
doi : 10.1097/RHU.0000000000001923
A subset of patients with idiopathic inflammatory myopathy (IIM) develops highly fatal, rapidly progressive interstitial lung disease (RP-ILD). Treatment strategies consist of glucocorticoid and adjunctive immunosuppressive therapies.
Sousa, Daniela Cabral de MD, MSc *,+; de Almeida, Samuel Brito MSc *; Roriz Filho, Jarbas de Sa MD, PhD *; Freitas, Thiago Holanda MD, PhD ++; Braga-Neto, Pedro MD, PhD *,[S]
doi : 10.1097/RHU.0000000000001888
During the last years, a growing number of studies have investigated the link between cognitive dysfunction and rheumatoid arthritis (RA), highlighting the potential pathogenic role of several clinical, psychological, and biological factors.
Graf, Cesar MD *; Fernandez-Avila, Daniel G. MD, MSc, PhD +; Plazzotta, Fernando MD ++; Soriano, Enrique R. MD, MSc [S],[//]
doi : 10.1097/RHU.0000000000001968
AB Telemedicine is the delivery of health care services by health care professionals using information and communication technologies to exchange valid information for the diagnosis, treatment, and prevention of diseases.
Dourado, Eduardo MD *,+; Valido, Ana MD ++
Aung, Tun Tun DO *; Siva, Chokkalingam MD, MS, FACP +
Umemoto, Daichi MD; Nishioka, Hiroaki MD, PhD
Zhu, Fenglin BS, Med; Li, Chengyin MD
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟